Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingyi Liang

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 20, 2021
Efficacy and Safety of Lianhuaqingwen Capsules, a repurposed Chinese Herb, in Patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242]Ke Hu, Wei-Jie Guan, Ying Bi, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 14, 2021
Efficacy and safety of Lianhua Qingwen capsules, a repurposed Chinese herb, in patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242]Ke Hu, Wei-Jie Guan, Ying Bi, et al.
Pulmonary Circulation|August 16, 2021
Bufei huoxue capsules in the management of convalescent COVID-19 infection: study protocol for a multicenter, double-blind, and randomized controlled trialYuqin Chen, Wenjun He, Wenju Lu, et al.
Open Forum Infectious Diseases|August 16, 2021
Critical Review of the Scientific Evidence and Recommendations in COVID-19 Management GuidelinesJiaxing Xie, Zhufeng Wang, Jingyi Liang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 19, 2021
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trialKe Hu, Wei-Jie Guan, Ying Bi, et al.
Journal of Thoracic Disease|April 11, 2020
Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventionsZifeng Yang, Zhiqi Zeng, Ke Wang, et al.
Frontiers in Microbiology|February 14, 2022
Different Circulation Pattern of Multiple Respiratory Viruses in Southern China During the COVID-19 PandemicZhiqi Zeng, Wenda Guan, Yong Liu, et al.
Frontiers in Public Health|January 9, 2023
How fast and how well the Omicron epidemic was curtailed. A Guangzhou experience to shareWenfeng Cai, Zifeng Yang, Jingyi Liang, et al.
National Science Review|February 9, 2026
Emerging local chikungunya virus transmission in a major urban area in Southern China: characteristics of clinical manifestations, viral evolution and climatic influencesJingyi Liang, Haisheng Yu, Zhengshi Lin, et al.
National Science Review|May 2, 2022
Crucial control measures to contain China's first Delta variant outbreakLei Luo, Zifeng Yang, Jingyi Liang, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 20, 2021
Efficacy and Safety of Lianhuaqingwen Capsules, a repurposed Chinese Herb, in Patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242]Ke Hu, Wei-Jie Guan, Ying Bi, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 14, 2021
Efficacy and safety of Lianhua Qingwen capsules, a repurposed Chinese herb, in patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242]Ke Hu, Wei-Jie Guan, Ying Bi, et al.
Pulmonary Circulation|August 16, 2021
Bufei huoxue capsules in the management of convalescent COVID-19 infection: study protocol for a multicenter, double-blind, and randomized controlled trialYuqin Chen, Wenjun He, Wenju Lu, et al.
Open Forum Infectious Diseases|August 16, 2021
Critical Review of the Scientific Evidence and Recommendations in COVID-19 Management GuidelinesJiaxing Xie, Zhufeng Wang, Jingyi Liang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 19, 2021
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trialKe Hu, Wei-Jie Guan, Ying Bi, et al.
Journal of Thoracic Disease|April 11, 2020
Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventionsZifeng Yang, Zhiqi Zeng, Ke Wang, et al.
Frontiers in Microbiology|February 14, 2022
Different Circulation Pattern of Multiple Respiratory Viruses in Southern China During the COVID-19 PandemicZhiqi Zeng, Wenda Guan, Yong Liu, et al.
Frontiers in Public Health|January 9, 2023
How fast and how well the Omicron epidemic was curtailed. A Guangzhou experience to shareWenfeng Cai, Zifeng Yang, Jingyi Liang, et al.
National Science Review|February 9, 2026
Emerging local chikungunya virus transmission in a major urban area in Southern China: characteristics of clinical manifestations, viral evolution and climatic influencesJingyi Liang, Haisheng Yu, Zhengshi Lin, et al.
National Science Review|May 2, 2022
Crucial control measures to contain China's first Delta variant outbreakLei Luo, Zifeng Yang, Jingyi Liang, et al.
Pageof 11